Determining the ideal retatrutide amount is critically necessary for seeing desired outcomes . Initially, patients typically begin with a modest quantity of approximately 2.4 mg, provided every week via subcutaneous . This starting dose is then progressively raised every four weeks , reaching a peak dose of 10.8 mg, based on individual response an